Sun Young Rha
Impact in
- Pulmonary and Respiratory Medicine top 0.05%
- Renal cell carcinoma treatment
- Gastric Cancer Management and Outcomes
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Gastric Cancer Management and Outcomes 126
- Renal cell carcinoma treatment 66
- Lung Cancer Treatments and Mutations 23
- Sarcoma Diagnosis and Treatment 20
- Oncology 184
- Colorectal Cancer Treatments and Studies 43
- HER2/EGFR in Cancer Research 35
- Cancer Immunotherapy and Biomarkers 25
- Co-authors
- Hyun Cheol Chung (240 shared papers)Hei‐Cheul Jeung (117 shared papers)Sung Hoon Noh (84 shared papers)Joong Bae Ahn (72 shared papers)Jae Kyung Roh (82 shared papers)Toni K. Choueiri (29 shared papers)Frede N. Donskov (19 shared papers)Lori Anne Wood (18 shared papers)
- Journals
- Annals of Oncology (72 papers)Cancer Research and Treatment (42 papers)Journal of Clinical Oncology (16 papers)Cancer Chemotherapy and Pharmacology (14 papers)Oncology (14 papers)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Sun Young Rha
585 papers receiving 26.0k citations
Sun Young Rha's Hit Papers
Peers
Comparison fields: 5 of 162
- Pulmonary and Respiratory Medicine 10.7k
- Oncology 8.0k
- Gastroenterology 1.3k
- Cancer Research 3.5k
- Molecular Biology 7.2k
Countries citing papers authored by Sun Young Rha
This map shows the geographic impact of Sun Young Rha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sun Young Rha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sun Young Rha more than expected).
Fields of papers citing papers by Sun Young Rha
This network shows the impact of papers produced by Sun Young Rha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sun Young Rha. The network helps show where Sun Young Rha may publish in the future.
Co-authors
The 25 scholars most cited alongside Sun Young Rha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 602 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma Hit paper breakdown → | 2021 | 1323 |
| 2 | Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study Hit paper breakdown → | 2011 | 937 |
| 3 | External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study Hit paper breakdown → | 2013 | 827 |
| 4 | Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2016 | 623 |
| 5 | A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets Hit paper breakdown → | 2012 | 574 |
| 6 | Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes Hit paper breakdown → | 2012 | 543 |
| 7 | 1999 | 485 | |
| 8 | 2007 | 462 | |
| 9 | Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial Hit paper breakdown → | 2023 | 435 |
| 10 | Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium Hit paper breakdown → | 2014 | 359 |
| 11 | Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer Hit paper breakdown → | 2022 | 358 |
| 12 | Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma Hit paper breakdown → | 2014 | 356 |
| 13 | The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study Hit paper breakdown → | 2015 | 320 |
| 14 | Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial Hit paper breakdown → | 2023 | 310 |
| 15 | 2011 | 304 | |
| 16 | PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer Hit paper breakdown → | 2021 | 260 |
| 17 | 2017 | 248 | |
| 18 | Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study Hit paper breakdown → | 2023 | 231 |
| 19 | 2014 | 226 | |
| 20 | 2013 | 214 |
About Sun Young Rha
Sun Young Rha is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Surgery, having authored 602 papers that have together received 26.5k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (126 papers), Renal cell carcinoma treatment (66 papers), Colorectal Cancer Treatments and Studies (43 papers), HER2/EGFR in Cancer Research (35 papers), Cancer Immunotherapy and Biomarkers (25 papers), Lung Cancer Treatments and Mutations (23 papers), Sarcoma Diagnosis and Treatment (20 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (10.7k citations), Oncology (8.0k citations), Gastroenterology (1.3k citations), Cancer Research (3.5k citations) and Molecular Biology (7.2k citations). Sun Young Rha has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Hyun Cheol Chung, Hei‐Cheul Jeung, Sung Hoon Noh, Joong Bae Ahn, Jae Kyung Roh, Toni K. Choueiri, Frede N. Donskov, Lori Anne Wood, Hyo Song Kim and Brian I. Rini. Their work appears in journals such as Annals of Oncology, Cancer Research and Treatment, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.